The first participant in the Moderna Phase III COVID-19 vaccine trial was enrolled this morning by Dr. Paul Bradley, Principal Investigator at Meridian’s internal medicine site in Savannah, GA. Compliments to Moderna on this significant milestone for its mRNA vaccine candidate (mRNA-1273) against COVID-19. 📰 Full release: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-phase-3-cove-study-mrna-vaccine-against-covid
Brandon Essink, MD, CPI, is a co-principal investigator for the Phase III clinical trial of Moderna’s COVID-19 vaccine. Read the full National Institutes of Health (NIH) press release: https://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins
Meridian Clinical Research, a leading multi-specialty investigative research network, has opened new sites in Grand Island, NE, and Hastings, NE. Meridian is partnering with Adam Brosz, MD, Erica Haake, MD, and Timothy Gardner, MD, in Grand Island. The physicians will serve as principal investigators to conduct clinical trials related to general medicine, women’s health, … Read more
The first participant in the Moderna Phase II COVID-19 vaccine trial was enrolled this morning by Keith Vrbicky, MD, Meridian Principal Investigator in Norfolk, NE. Congratulations to Moderna for making remarkable progress on its mRNA vaccine against novel coronavirus. 📰 Full release: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-each-age-cohort-dosed-phase
Meridian Clinical Research, a leading investigative research network, is seeking participants for COVID-19 vaccine clinical trials in the following areas: Nebraska (Norfolk and Omaha), Georgia (Savannah), and South Dakota (Dakota Dunes). The studies will help determine the safety and efficacy of investigational vaccines intended to protect against SARS-CoV-2 (the coronavirus that causes COVID-19). To … Read more
Andrew Kimball, vice president, business development (BD), recently published an article in SCRS InSite that highlights the importance of BD at research sites and networks. The article outlines BD’s role in enhancing feasibility processes, opportunity sourcing, and the nurturing of long-term partnerships with Sponsors and CROs. ? Full article: https://cloud.3dissue.com/180561/181052/211361/SpringInsite2020/index.html?page=6
Meridian Clinical Research, a leading investigative research network, will remain open to support the research of investigational tests, vaccines, and medications intended for commercial release. Meridian sites are working with Sponsors and contract research organizations (CROs) to ensure patient safety while continuing to enroll patients during the COVID-19 pandemic. The company has enrolled more … Read more
Meridian Clinical Research, a leading investigative research network, is a finalist to win the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which is a finalist for the Best Clinical Trial Network award. These nominations were the result of two voting … Read more
Omaha, Neb., December 17, 2019 — Meridian Clinical Research, a leading investigative research network, has donated more than $290,000 to people in need, fundraisers, and charitable organizations in 2019. The amount was accumulated through a novel employee incentive program that intertwines annual bonus and charitable giving budgets. “Our communities and our patients are at … Read more
Three Meridian principal investigators were voted Best of Savannah Doctors 2019 by Savannah Magazine readers. The award winners include: Buffi G. Boyd, MD, of Urological Associates of Savannah, PC for Best Urologist Corinne Howington, MD, of Low Country Dermatology for Best Dermatologist Michael Hemphill, MD, of Savannah Neurology Specialists for Best Neurologist Read Savannah Magazine’s Best of Savannah … Read more
Meridian Clinical Research, a leading investigative research network, is celebrating its twentieth year in business. Meridian was founded by Nicole Osborn, the company’s CEO, in 1999. It began as a single research site in Omaha, Neb., where the company is headquartered. Meridian added locations in Norfolk, Neb., and Dakota Dunes, S.D., before establishing a … Read more
Meridian Clinical Research, LLC, based in Omaha, NE, has acquired the assets and operations of Regional Clinical Research, Inc., expanding its North American footprint to more than 20 investigative sites. Regional was established in 1993 by Bruce Bowling, MD, and Victor Elinoff, MD, and operates four research sites in the southern tier of New … Read more
Bounphone Chanthavong (Willow), MPH, CCRC, is your 2019 PharmaTimes Clinical Research Coordinator of the Year! Willow is a research coordinator at Meridian’s neurology site in Savannah, Ga., and won the award on May 4, 2019, after a three-stage competition involving an initial online test, a written essay challenge, and an in-person presentation in Boston. … Read more
Platinum Research Network was named highly commended for the Best Clinical Site or Network category at the 2018/2019 Vaccine Industry Excellence (ViE) Awards. The award recognizes investigative site networks that support diverse clinical trials for vaccines, introduce novel services to improve performance, achieve rapid enrollment, and uphold high subject retention. — Meridian Clinical Research … Read more
Meridian Clinical Research and Savannah Plastic Surgery are partnering to conduct clinical trials in Savannah, Ga. Dr. Luke Curtsinger and Dr. Matthew McLeod at Savannah Plastic Surgery will serve as principal investigators and lead the conduct of research studies for novel surgical approaches, pharmaceutical products, and medical devices. “Clinical research makes progress possible,” said … Read more
Savannah, Ga., April, 2, 2019 — Bounphone “Willow” Chanthavong, MPH, CCRC, director and research coordinator at Meridian’s neurology site in Savannah, Ga., was selected as a finalist for the PharmaTimes Clinical Researcher of the Year — The Americas 2019. The finals are the third stage of a competition that welcomes the highest scoring candidates … Read more
Norfolk, Va., March, 4, 2019 — Ingrid Loma-Miller, MD, has been selected to serve on the National Medical Advisory Committee for the National Multiple Sclerosis Society (NMSS). She is a principal investigator at Meridian Clinical Research, and is a physician at Neurology Specialists, a division of Neurology Consultants of Tidewater, PLLC in Norfolk, Va. … Read more
Congratulations to Keith Vrbicky, MD! He was named Faith Regional’s 2018 Physician of the Year. Charles Harper, MD, a Meridian principal investigator, was also recognized for 10 years of service at Faith Regional. Read the full announcement here.
For 2018’s Good Deeds Day, employees at each Meridian site were given a cash stipend and a simple instruction: Go into your community and make a difference. We were blown away by the thoughtfulness with which each Meridian site chose to donate to the community, support local charities, or perform small acts of kindness. … Read more
Evofem Biosciences, Inc. (NASDAQ: EVFM) (“Evofem” or the “Company”) today announced that its Phase 3 clinical trial of Amphora® for the prevention of pregnancy, AMPOWER, successfully met its primary endpoint. AMPOWER assessed the efficacy, safety and subject satisfaction with Amphora in approximately 1,400 healthy women aged 18-35 years at 112 centers in the U.S. … Read more
Find a Study
When people like you participate in a clinical trial, we can uncover better ways to treat conditions that may affect you and your loved ones. Sign up for more information about clinical trials near you: mcrmed.com/find-study